Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michio Masuoka is active.

Publication


Featured researches published by Michio Masuoka.


Transgenic Research | 2008

Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models

Seiya Inoue; Mika Ohta; Zhenghua Li; Gang Zhao; Yutaka Takaoka; Naomi Sakashita; Kazuhisa Miyakawa; Koji Takada; Hajime Tei; Misao Suzuki; Michio Masuoka; Yoshiyuki Sakaki; Kiyoshi Takahashi; Ken Ichi Yamamura

Transthyretin (TTR) associated amyloidosis is an autosomal dominant disorder characterized by peripheral and autonomic neuropathy. Both genetic and environmental factors are thought to be involved in development of TTR associated amyloidosis. Previously, we demonstrated that amyloid deposition was observed in various tissues of transgenic mouse lines carrying a human mutant TTR (Met30) gene. To analyze the influence of environmental factors on TTR amyloidosis, these amyloidogenic transgenic mouse models were kept under conventional (CV) or specific pathogen free (SPF) conditions. Although the serum levels of Met30 for mice housed in the CV and SPF conditions were similar, amyloid deposition was observed in CV conditions, but not in SPF conditions. In addition, the extent of amyloid deposition in transgenic mice was dependent on duration kept under CV conditions. There were significant differences in proportion of amyloid deposition in several tissues between CV and SPF conditions. Maintenance of these mice at 30°C did not induce amyloid deposition in SPF conditions. These results suggest that the SPF conditions can completely prevent amyloid deposition, and that environmental factors can affect the onset and progression even in a single gene disorder.


Studies in Environmental Science | 1986

Effects of Fluoride on Developing Enamel and Dentin of Rat Incisors

Toshio Abe; Michio Masuoka; Masaji Nomura; Hiroaki Miyajima

Abstract The effects of fluoride on the developing enamel and dentin of rat incisors were investigated. Rats were treated orally with the anti-neoplastic agents, Tegafur and ethyl t-6-butoxy-5-fluorohexahydro-2, 4-dioxopyrimi-dine-r-5-carboxylate (TAC-278), and NaF at different doses for eight weeks. These anti-neoplastic agents contain fluorine (F) and appeared to release 5-fluorouracil after the treatment. Tegafur and TAC-278 induced mottled enamel characterized by pigment-free and chalky white areas. Histo-pathologically, ameloblasts, at the secretory to maturation stage, showed degeneration and necrosis, and formed a cystic irregular array. In the dentin, there were focal or diffuse hypoplastic defects resulting from degeneration and atrophy of odontoblasts. Microradiographically, calcio-traumatic lines resulting from damage to secretory ameloblasts, and calcio-traumatic zones resulting from damage to ameloblasts at the maturation stage were observed in the enamel. These changes were essentially the same as the abnormality resulting from NaF treatment. The F concentration in the incisors was highest in the NaF treated rats, and lowest in the TAC-278 treated rats. The severity of gross lesion of the incisors and the F concentration in the incisors were well correlated. From these results, it is suggested that, like NaF, an excessive dose of Tegafur or TAC-278 affects the developing enamel and dentin of rat incisors.


Chemical & Pharmaceutical Bulletin | 1978

Synthesis and Antiandrogenic Activity of 16β-Substituted-17β-hydroxysteroids

Giichi Goto; Kouichi Yoshioka; Kentaro Hiraga; Michio Masuoka; Ryo Nakayama; Takuichi Miki


Archive | 1973

16{62 -hydrocarbon substituted estrane compounds

Giichi Goto; Ryo Nakayama; Kentaro Hiraga; Kouichi Yoshioka; Michio Masuoka


Japanese Journal of Pharmacology | 1970

PHARMACOLOGICAL STUDIES OF INSECT METAMORPHOSING HORMONE: PONASTERONE A, ECDYSTERONE, AND INOKOSTERONE, IN THE RAT

Michio Masuoka; Shigeru Orita; Akio Shino; Tai Matsuzawa; Ryo Nakayama


Journal of pharmacobio-dynamics | 1984

RADIOIMMUNOASSAY FOR SERUM LEVELS OF AN ANTIANDROGEN TSAA-291 (OXENDOLONE) IN RATS

Katsuichi Sudo; Michio Masuoka; Kentaro Hiraga; Keiji Yoshida; Ryo Nakayama


Archive | 1974

17-Nor-6-methyl-steroids

Kentaro Hiraga; Kouichi Yoshioka; Giichi Goto; Ryo Nakayama; Michio Masuoka


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1983

[Synthesis and antiandrogenic activity of 17-deoxysteroids].

Yutaka Masuoka; Michio Masuoka; Giichi Goto; Kentato Hiraga; Ryo Nakayama; Takuichi Miki; Masao Sumi


European Journal of Endocrinology | 1979

Anti-androgen TSAA-291. I. Anti-androgenic effects of a new steroid TSAA-291 (16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one) and its derivatives.

Ryo Nakayama; Michio Masuoka; Tsuneo Masaki; Shimamoto K


Archive | 1970

17BETA-PHENOXYACETYLOXYESTR-4-EN-3-ONES

Takuichi Miki; Kentaro Hiraga; Tsunehiko Asako; Toru Yui; Michio Masuoka

Collaboration


Dive into the Michio Masuoka's collaboration.

Top Co-Authors

Avatar

Ryo Nakayama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takuichi Miki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Giichi Goto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toru Yui

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tsunehiko Asako

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Iwao Yamazaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kouichi Yoshioka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tsuneo Masaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mutsushi Shikata

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge